EUVIMEDEUVIMED entdecken
Crossref

Anti‐Inflammatory Mechanisms of Lysilactones and Diketopiperazine Alkaloids From Lysimachia paridiformis

Lulu Li, Jinfang Luo, Hua Huang, Jianghai Ye, Yichun Sun, Peng Wei, Chenliang Zhao, Mei Yang, Juan Zou iD, Kang He

Chemistry & Biodiversity · 2026-04 · 23 (4)

DOI: 10.1002/cbdv.202502340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 01.04.2026. Verfasst von Lulu Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, China. Hauptthemen laut MEDLINE: Alkaloids, Diketopiperazines, Lysimachia, Anti-Inflammatory Agents. Die Arbeit nennt 63 Literaturangaben. Gefördert von: Guizhou Provincial Basic Research Program (Natural Science), Guizhou Provincial Department of Education Natural Science Research Program, Sinopharm Group Tongjitang (Guizhou) Pharmaceutical Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The whole plant of Lysimachia paridiformis var. stenophylla Franch. (known as “Kod tud vud” in Chinese Miao medicine) has been used for the treatment of inflammation for a long time. However, its bioactive components and underlying mechanisms against inflammation are still unclear. The compounds were extracted and separated using silica gel chromatography, followed by further purification with Sephadex LH‐20 and MCI gel CHP 20P. Their structures were identified through physical and chemical characteristics as well as spectral data. Network pharmacology was used to predict the potential anti‐inflammatory targets and pathways of these compounds, with the results validated through LPS‐induced cell models. A new lysilactone, 2,7,9‐trihydroxy‐3‐methoxy‐1‐methyl‐6 H ‐benzo[ c ]chromen‐6‐one ( 1 ), has been isolated from “Kod tud vud.” In addition, five known compounds were obtained, including three lysilactone compounds, one diketopiperazine‐type indole alkaloid, and the diketopiperazine alkaloid 3,6‐diisopropyl‐2,5‐diketopiperazine ( 6 ). Compounds 1 and 6 significantly inhibited nitric oxide (NO) production and the expression of interleukin‐1 β (IL‐1 β ), interleukin‐6 (IL‐6), tumor necrosis factor‐ α (TNF‐ α ), cyclooxygenase‐2 (COX‐2), and inducible nitric oxide synthase (iNOS) in LPS‐induced macrophages. Mechanistic studies revealed that these effects were achieved by reducing p65 phosphorylation and preventing its nuclear translocation, thereby decreasing the activation of the NF‐ κ B pathway. Overall, these findings suggest that compounds 1 and 6 may be potential therapeutic agents for inflammation by inhibiting the NF‐ κ B signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlkaloidsDiketopiperazinesLysimachiaAnti-Inflammatory AgentsLactonesAnti-Inflammatory Agents, Non-SteroidalAnimalsLipopolysaccharidesRAW 264.7 CellsNitric OxideMiceNF-kappa BNitric Oxide Synthase Type IIMacrophagesCyclooxygenase 2Molecular Structure

Stichwörter der Autor:innen

Lysimachia paridiformisNF‐κBanti‐inflammatorydiketopiperazine‐type alkaloidlysilactone

Substanzen

LipopolysaccharidesAlkaloidsDiketopiperazinesNitric OxideAnti-Inflammatory AgentsLactonesNF-kappa BNitric Oxide Synthase Type IICyclooxygenase 2Anti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
  • Guizhou Key Laboratory of Miao Medicine, Guiyang, China.
  • School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
  • Sinopharm Group Tongjitang (Guizhou) Pharmaceutical Co., Ltd., Guiyang, P. R. China.

ORCID-Profile: Juan Zou

Förderung

  • Guizhou Provincial Basic Research Program (Natural Science)
  • Guizhou Provincial Department of Education Natural Science Research Program
  • Sinopharm Group Tongjitang (Guizhou) Pharmaceutical Co., Ltd.

Zitieren

APA

Li, L., Luo, J., Huang, H., Ye, J., Sun, Y., Wei, P., Zhao, C., Yang, M., Zou, J., & He, K. (2026). Anti‐Inflammatory Mechanisms of Lysilactones and Diketopiperazine Alkaloids From Lysimachia paridiformis. Chemistry & Biodiversity, 23(4). https://doi.org/10.1002/cbdv.202502340

Vancouver

Li L, Luo J, Huang H, Ye J, Sun Y, Wei P, et al. Anti‐Inflammatory Mechanisms of Lysilactones and Diketopiperazine Alkaloids From Lysimachia paridiformis. Chemistry & Biodiversity. 2026;23(4). doi:10.1002/cbdv.202502340

BibTeX
@article{Li2026,
  author = {Li, Lulu and Luo, Jinfang and Huang, Hua and Ye, Jianghai and Sun, Yichun and Wei, Peng and Zhao, Chenliang and Yang, Mei and Zou, Juan and He, Kang},
  title = {Anti‐Inflammatory Mechanisms of Lysilactones and Diketopiperazine Alkaloids From Lysimachia paridiformis},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {4},
  doi = {10.1002/cbdv.202502340}
}
Kostenlos starten →